- $5.92bn
- $8.22bn
- CA$4.20bn
- 92
- 44
- 54
- 68
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,304 | 3,623 | 2,982 | 3,371 | 4,203 |
Cost of Revenue | |||||
Gross Profit | 942 | 1,084 | 765 | 956 | 1,166 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,824 | 3,086 | 2,934 | 3,087 | 3,729 |
Operating Profit | 481 | 537 | 48.4 | 284 | 474 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 400 | 393 | -87.2 | 154 | 296 |
Provision for Income Taxes | |||||
Net Income After Taxes | 340 | 319 | -47.5 | 150 | 232 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 330 | 311 | -47.2 | 142 | 223 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 330 | 311 | -47.2 | 142 | 223 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.26 | 1.31 | -0 | 0.862 | 0.857 |
Dividends per Share |